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Abstract: When isolated from mammalian cell nuclei, all nuclear pre-mRNAs are packaged 
in multi-subunit large ribonucleoprotein complexes—supraspliceosomes—composed of four 
native spliceosomes interconnected by the pre-mRNA. Supraspliceosomes contain all five 
spliceosomal U snRNPs, together with other splicing factors, and are functional in splicing. 
Supraspliceosomes studied thus far represent the steady-state population of nuclear  
pre-mRNAs that were isolated at different stages of the splicing reaction. To analyze 
specific splicing complexes, here, we affinity purified Pseudomonas aeruginosa phage 7 
(PP7)-tagged splicing complexes assembled in vivo on Adenovirus Major Late (AdML) 
transcripts at specific functional stages, and characterized them using molecular techniques 
including mass spectrometry. First, we show that these affinity purified splicing complexes 
assembled on PP7-tagged AdML mRNA or on PP7-tagged AdML pre-mRNA are 
assembled in supraspliceosomes. Second, similar to the general population of 
supraspliceosomes, these defined supraspliceosomes populations are assembled with all 
five U snRNPs at all splicing stages. This study shows that dynamic changes in  
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base-pairing interactions of U snRNA:U snRNA and U snRNA:pre-mRNA that occur  
in vivo during the splicing reaction do not require changes in U snRNP composition of the 
supraspliceosome. Furthermore, there is no need to reassemble a native spliceosome for the 
splicing of each intron, and rearrangements of the interactions will suffice. 
Keywords: pre-mRNA splicing; specific supraspliceosomes; U snRNPs; PP7-tagged 
supraspliceosomes 
 
1. Introduction 
The maturation of all pre-mRNA expressed from human protein-coding genes requires the 
processing of the pre-mRNA to an mRNA that can be transported from the nucleus to the cytoplasm to 
encode for proteins. The processing steps include capping of the 5' end, processing of the 3' end, 
editing and splicing. Splicing of the pre-mRNA molecule occurs within the spliceosome, a huge 
ribonucleoprotein (RNP) complex. The accuracy and efficiency of pre-mRNA splicing is attributed  
to a number of trans-acting factors, which include the spliceosomal uridine-rich small nuclear 
ribonucleoprotein complexes (U1, U2, U4, U5, and U6 snRNPs) and several non snRNP protein 
splicing factors, as well as to cis-acting sequence elements. The latter include 5' and 3' splice sites,  
a branch point, and a polypyrimidine tract. Splicing enhancers and silencers are additional control 
elements, which play an important role in both constitutive and alternative splicing by interacting with 
splicing factors, such as the Serine/Arginine (SR) rich protein family [1]. 
Studies in vitro have shown that the assembly of the spliceosome occurs in a stepwise manner [2–4]. 
The U snRNPs are central components of the spliceosome. They participate in splice-site recognition 
and have an essential function in splicing through cooperative RNA:RNA interactions between the 
snRNAs and the pre-mRNA [2,3,5]. The assembly of the spliceosome involves an intricate series of 
interactions between the five major U snRNPs, as well as with a number of non-snRNP splicing 
factors, which are dynamically recruited to the spliceosome when an exogenous pre-mRNA is added to 
a nuclear extract. A pre-catalytic complex involves the five-spliceosomal U snRNPs, yet the splicing 
active complex contains U2.U5/U6 snRNPs [1]. 
Regulated splicing, as well as constitutive splicing, operates through the combinatorial interplay  
of positive and negative regulatory signals present in the pre-mRNA, which are recognized by  
trans-acting factors. The most studied of the latter are members of the hnRNP and SR protein families. 
SR proteins, characterized by serine and arginine-rich protein motive, bind RNA through their RNA 
recognition motives (RRMs), while their SR domain appears to enable protein–protein and  
protein–RNA interactions during the splicing reaction. SR proteins show distinct RNA binding 
specificities for exonic splicing enhancers (ESEs), and multiple binding sites for several SR proteins 
are found in the same exon [6–8]. The hnRNP proteins are a diverse group of RNA binding proteins, 
with an RNA-binding domain (RBD). They are associated with RNA Pol II transcripts and play a key 
role in regulation of pre-mRNA splicing [9]. The high fidelity of exon recognition is thus achieved by 
the combination of multiple weak protein:protein, protein:RNA, and RNA:RNA interactions. 
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The composition of splicing complexes assembled in vitro was analyzed by mass  
spectrometry [1,10,11], mainly of affinity purified RNA-tagged spliceosomes. These studies showed 
over hundred proteins that are associated with the in vitro assembled spliceosome, and reported 
changes in protein composition that occurred during the splicing reaction. Mass spectrometry analysis 
of the general population of splicing complexes isolated from nuclei and co-immunoprecipitated by 
anti-Sm MAbs revealed 177 polypeptides [12]. 
When isolated from mammalian cell nuclei, Pol II transcripts are found assembled in huge  
(21 MDa) nuclear RNP particles termed supraspliceosomes. The entire repertoire of nuclear  
pre-mRNAs, independent of their length or the number of introns they contain, appear to be assembled 
in splicing-active supraspliceosomes [13]. Supraspliceosomes harbor all five spliceosomal U snRNPs 
and splicing factors [14,15]. In addition to the constitutive splicing factors, a number of splicing 
regulatory factors were found to be predominantly associated with supraspliceosomes. These include 
all phosphorylated SR proteins [16]; the splicing regulatory factor hnRNP G [17]; and the alternative 
splicing factors RBM4 and WT1, which co-interact to influence alternative splicing [18], and the 
regulatory splicing factor ZRANB2 [19]. Supraspliceosomes also harbor other components of  
pre-mRNA processing, such as the cap-binding proteins, components of the 3' end processing  
activity [20], and the editing enzymes ADAR1 and ADAR2 [21]. Taken together, these observations 
support the view that the supraspliceosome is the nuclear pre-mRNA processing machine. 
Structural studies revealed that the supraspliceosome is composed of four apparently similar 
splicing active substructures—native spliceosomes—each resembling an in vitro assembled 
spliceosome, which are connected by the pre-mRNA [15,22–26]. The 3-D structure of the native 
spliceosome was determined by the cryo-electron microscopy (cryo-EM) single particle technique at  
a resolution of 20 Å, and revealed an elongated globular particle composed of a large and a small 
subunit [25]. Within the supraspliceosome, the native spliceosomes are arranged such that their  
small subunits reside in its center. This configuration allows communication between the native 
spliceosomes, which is a crucial element for regulated splicing and for quality control of the  
resulting mRNAs [15,26]. 
Previous studies of supraspliceosomes analyzed the steady state population of nuclear complexes 
assembled on the general population of Pol II transcripts, having different sequences and number of 
introns and likely assembled at different stages of the splicing reaction. Here we focused on analysis of 
splicing complexes assembled on a specific transcript at a defined functional state. For this aim we 
affinity purified splicing complexes assembled on transcripts harboring a Pseudomonas aeruginosa 
phage 7 (PP7)-tag, which we inserted in the 3'UTR or in the intron. We show that the affinity purified 
splicing complexes, which were isolated via their PP7-tag, are assembled in supraspliceosomes.  
We further show that supraspliceosomes assembled on a specific mRNA or pre-mRNA contain all five 
spliceosomal U snRNPs. We can, thus, conclude that supraspliceosomes isolated from mammalian cell 
nuclei have all five spliceosomal U snRNAs associated with them at all splicing stages. However, we 
do observe some differences in the protein composition of supraspliceosomes from the different 
splicing stages. 
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2. Results and Discussion 
The structural and functional analysis of supraspliceosomes performed so far was of the steady  
state population of complexes assembled on the general population of nuclear pre-mRNAs,  
each harboring a different number of introns and is likely to represent a different step of the splicing  
process [13–15,22,24,27]. Importantly, solving the structure of the supraspliceosome, at 20 Å 
resolution [25], and the fact that the scanning transmission EM (STEM) mass measurements revealed a 
relatively uniform mass for the supraspliceosome (21.1 ± 1.6 MDa; n = 400) [24], likely reflects the 
presence of a general basic structure—the supraspliceosome—that at this resolution is similar for the 
different transcripts. During the steps of the splicing reaction, changes in RNA–RNA, protein–RNA 
and protein–protein interaction occur [5,28]. In order to study how the changes in these internal 
interactions are reflected in the supraspliceosome, we affinity purified and analyzed supraspliceosomes 
assembled on specific transcripts, isolated at defined functional states (pre-mRNA or mRNA).  
The isolation was based on preparation of stable cell lines transcribing specific RNA-tagged 
transcripts, and the isolation of splicing complexes assembled on transcripts at defined functional 
states was based on mutations of genes encoding specific pre-mRNAs. 
2.1. Generation of Stable Cell Lines Expressing Pseudomonas aeruginosa Phage 7 (PP7)-Tagged 
Adenovirus Major Late (AdML) Transcripts 
For this approach we used the “RNA Affinity in Tandem” system [29]. This RNA tag-based 
method uses the Pseudomonas aeruginosa phage 7 (PP7) RNA binding site to tag the RNA, and was 
developed for affinity purification of endogenously assembled RNP complexes. Affinity purification is 
mediated by a recombinant PP7 coat protein (PP7CP), as an N-terminal fusion to two Protein A 
domains (ZZ), with an intervening linker for cleavage by Tobacco Etch Virus (TEV) protease 
(ZZTEVPP7CP). The PP7CP binds to the RNA tag with high affinity and high selectivity under 
various conditions including physiological conditions [30,31]. Recovery of the coat protein and 
associated RNPs was achieved using IgG agarose beads and elution from washed resin by addition of 
TEV protease. As the yield of this method was found to be higher than the MS2/R17 system [29],  
it seemed advantageous for our study. 
We, thus, prepared a number of constructs of Adenovirus Major Late (AdML) harboring a PP7 tag, 
and cloned them into pcDNA3 vector (Figure 1). Two wild type (WT) AdML constructs were  
prepared (Figure 1A): one with no tag (AdML-WT), and a second, with the tag at the 3'UTR  
(AdML-WT-PP73'UTR). We also prepared three Mutant (Mut) clones that are inhibited after the first 
step of splicing (Figure 1B). One, mutant construct without a tag (AdML-Mut); Second, a Mut AdML 
construct with a PP7 tag at the 3'UTR (AdML-Mut-PP73'UTR); and a third construct of Mut AdML with 
the PP7 tag at the intron (AdML-Mut-PP7IVS). All constructs were confirmed by sequencing. We next 
prepared five HeLa stable cell lines, each stably expressing one of the above constructs, respectively. 
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Figure 1. Scheme of the affinity purification of specific supraspliceosomes.  
(A,B) Schemes of AdML constructs used for preparation of stable cell lines, each 
expressing one of the constructs used for the affinity purification of specific 
supraspliceosomes at defined splicing stages. (A) Constructs expressing AdML-WT;  
(B) constructs expressing AdML-Mut, having a mutated 3' splice site, designated “x”.  
The upper schemes represent the control construct without PP7 tag. The middle scheme of 
(B) and the lower scheme of (A) represent the constructs harboring the PP7 tag at the 
3'UTR. The lower scheme of (B) represents the construct harboring the PP7 tag at the 
intron. Open boxes represent exons, lines represent introns, and stem-loops represent the 
PP7 tag; (C) Scheme of the affinity purification process of specific splicing complexes 
assembled on a specific transcript. First, nuclear supernatants enriched in splicing 
complexes (scheme in yellow) are extracted from HeLa cell-lines expressing the respective 
AdML construct. A fusion protein ZZTEVPP7CP (Purple; Z: ZZ; T: TEV; P: PP7CP) is 
then added, and the PP7CP part bind the PP7 tag. Next, IgG agarose beads (Blue, Green, 
respectively) were added for binding of the ZZ part of the fusion protein to the antibody, 
followed by sedimentation and washing of the beads. The elution of splicing complexes 
(Yellow) assembled on the respective specific transcript harboring the PP7 tag, and bound 
to the PP7CP, is performed by digestion with TEV protease (Black scissors). 
 
2.2. Affinity Purification of Complexes Assembled on AdML-WT Transcripts 
Affinity purification of splicing complexes assembled on PP7-tagged AdML-WT transcripts was 
performed as described in the Experimental Section (see schematics in Figure 1C). Briefly, a HeLa cell 
line stably expressing AdML-WT with a PP7 tag at the 3'UTR (AdML-WT-PP73'UTR) was grown in 
tissue culture, and nuclear supernatants were prepared as described [15]. Next, the nuclear supernatants 
were incubated with ZZTEVPP7CP, and the reaction mixture was further incubated with Rabbit IgG 
Int. J. Mol. Sci. 2014, 15 11642 
 
 
beads, followed by washing of the beads. For elution of the splicing complexes the reaction was 
incubated overnight, with TEV protease. After pelleting the beads, the supernatant was collected and 
analyzed. As control, we performed, in parallel, the whole procedure with nuclear supernatants 
prepared from a HeLa cell line stably expressing AdML-WT without a tag. 
The specificity of the purification was first analyzed by RT-PCR (Figure 2A). As can be seen, 
mature AdML-WT RNA is eluted when AdML-WT-PP73'UTR is affinity purified, while no AdML 
RNA is eluted when nuclear supernatants prepared from a stable cell line expressing AdML-WT that 
lacks the PP7-tag are going through the same steps. As expected, actin transcripts that do not harbor 
the PP7 tag are not eluted. We also examined the protein profile of the eluted material by SDS-PAGE 
and silver staining (Figure 2B). While a large number of proteins are found in the affinity purified 
complexes assembled on AdML-WT-PP73'UTR, in the elution of AdML-WT we see mainly the light 
and heavy chains of IgG, originating from the beads, as well as the PP7CP. We next checked the 
affinity purification by Western Blot (WB), using antibodies against the Sm proteins, which are 
integral components of splicing complexes [4,20]. Figure 2C shows that Sm proteins are associated 
with the eluted AdML-WT-PP73'UTR splicing complexes, while only traces of Sm proteins are found  
in the control. We can, thus, conclude that we have affinity purified RNP complexes of the  
AdML-WT-PP73'UTR transcript. 
2.3. Affinity Purified PP7-Tagged AdML-WT Transcripts Are Assembled in Supraspliceosomes 
In previous studies we isolated supraspliceosomes by centrifugation in glycerol/sucrose gradients, 
and showed that Pol II transcripts are individually assembled in supraspliceosomes that sediment at 
200S in such gradients (reviewed in [13]). Since here we used a different protocol for isolation of 
splicing complexes assembled on PP7-tagged transcripts, namely by affinity purification of splicing 
complexes assembled on PP7-tagged transcripts, using recombinant PP7CP, we used glycerol gradient 
fractionation to determine the sedimentation velocity of the complexes in which the affinity  
purified AdML-WT-PP73'UTR transcripts are assembled. We, thus, loaded the affinity purified  
AdML-WT-PP73'UTR complexes on glycerol gradients and analyzed the distribution of AdML RNA 
across the gradient by RT-PCR. As can be seen in Figure 3A, AdML-WT-PP73'UTR transcripts were 
assembled in complexes that sediment at a sedimentation velocity that supraspliceosomes sediment, 
having a similar sedimentation to that of hnRNP G. It should be pointed out that we have previously 
shown that hnRNP G predominantly sediments with supraspliceosomes and is associated with them [17]. 
Further confirmation that affinity purified PP7-tagged AdML-WT-PP73'UTR transcripts are 
assembled in supraspliceosomes comes from EM visualization (Figure 3B). When aliquots from the 
eluted AdML-WT-PP73'UTR complexes were negatively stained and visualized by EM, the affinity 
purified splicing complexes of AdML-WT-PP73'UTR were observed assembled in supraspliceosomes, 
(Figure 3B, upper panel), similar in shape and dimensions to the 50 nm tetrameric quadrangular 
general population of supraspliceosomes [22,24]. In addition, the dimensions of the native 
spliceosomes within the supraspliceosome are similar to those found previously for the general 
population of native spliceosomes [24,25]. No supraspliceosomes were observed eluted from the control 
(Figure 3B, lower panel). We can thus conclude that AdML-WT-PP73'UTR transcripts are assembled in 
supraspliceosomes, and that the specific splicing complexes assembled on PP7-tagged AdML that were 
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affinity purified by the PP7/PP7CP system are supraspliceosomes. Furthermore, the specific 
supraspliceosomes assembled on AdML-WT-PP73'UTR are supraspliceosomes assembled on mature 
polyadnylated AdML (unspliced RNA could not be detected) as can be seen in Figure 2A. 
Figure 2. Analysis of affinity purified splicing complexes assembled on AdML-WT-
PP73'UTR. Nuclear supernatants prepared from cell lines stably expressing the AdML-
WT-PP73'UTR transcript, harboring the PP7 tag at the 3'UTR (left), or AdML-WT 
transcript without the tag (right), were affinity purified. Aliquots from the different steps 
of the affinity purification procedure were analyzed by RT-PCR (A); silver staining of  
SDS-PAGE (B); and WB (C). Lanes 1 and 8, Nuclear Supernatant (Nuc. Sup., 10%);  
Lanes 2 and 9, material not bound to the beads (Unbound); Lanes 3–6 and 10–13, washes; 
Lanes 7 and 14, elution. (A) RT-PCR products were electrophoresed on 1% agarose gel. 
Their identity is given on the left, open boxes represent exons, arrowheads represent the 
PCR primers. The expected size of each PCR product (nt) is given adjacent to its location 
on the left; (B) Proteins from the different steps of the affinity purification procedure were 
electrophoresed on 10% polyacrylamide gel and the gel was silver stained. Protein size 
marker is given on the left. *, heavy and light chains of the IgG antibody used for the 
affinity purification procedure; **, PP7CP protein; (C) Proteins from the different steps  
of the affinity purification procedure were electrophoresed on 12% polyacrylamide gel, 
transferred to a Nitrocellulose membrane and analyzed by WB using an anti-Sm antibody. 
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Figure 3. The affinity purified splicing complexes assembled in vivo on  
AdML-WT-PP73'UTR transcripts are supraspliceosomes. (A) Upper panel: Affinity 
purified splicing complexes assembled on the AdML-WT-PP73'UTR transcript, were 
fractionated in 10%–45% glycerol gradients, under the conditions used for fractionation of 
supraspliceosomes [15]. RNA was extracted from each fraction, analyzed by RT-PCR 
using the indicated AdML primer pair (arrowheads), and the amplified products were 
electrophoresed on 1% agarose gel. The size of the PCR product (nt) is given adjacent to 
its location, open boxes represent exons; Lower panel, Western Blot analysis of nuclear 
supernatants enriched for supraspliceosomes prepared from HeLa cells and fractionated in 
10%–45% glycerol gradients. Aliquots from gradient fractions were analyzed by WB using 
anti-hnRNP G antibody. hnRNP G was previously shown to predominantly sediment with 
supraspliceosomes and to be associated with them [17]; (B) Upper panel, Gallery of electron 
micrographs of affinity purified supraspliceosomes assembled on AdML-WT-PP73'UTR 
transcript, visualized by EM, after negative staining with 1% uranyl acetate; Lower panel, 
Control, electron micrograph of eluted material from the control sample (AdML-WT 
transcript without the PP7 tag). The bar represents 50 nm. 
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2.4. Affinity Purification of Supraspliceosomes Assembled on AdML-Mut Transcripts 
A similar affinity purification procedure was used to isolate supraspliceosomes assembled on 
AdML-Mut-PP73'UTR transcripts. These transcripts harbor a mutated 3' splice site and cannot 
undergo the second step of splicing. RT-PCR analysis of the affinity purified complexes assembled  
on AdML-Mut-PP73'UTR revealed the specificity of isolation, as no AdML-Mut transcripts were 
observed in the control harboring no tag, and also no actin transcripts were eluted (Figure 4A).  
The specificity is also confirmed by silver staining of SDS-PAGE and by Western Blot with  
anti-Sm antibodies (Figure 4B,C, respectively). The eluted transcripts are mainly AdML-Mut  
pre-mRNA (Figure 4A). EM visualization of eluted complexes assembled on AdML-Mut-PP73'UTR 
transcripts revealed supraspliceosomes (Figure 4D, upper panel), similar to those observed for the WT 
transcripts and similar in shape and dimensions to the 50 nm tetrameric quadrangular general 
population of supraspliceosomes [22,24], while no distinct complexes were observed in the control 
(Figure 4D, lower panel). Thus, affinity purification of nuclear complexes assembled on  
AdML-Mut-PP73'UTR transcripts yielded supraspliceosomes assembled on AdML-Mut pre-mRNA, 
having a PP7 tag at the 3'UTR. 
We next affinity purified splicing complexes assembled on AdML-Mut-PP7IVS. Affinity 
purification of splicing complexes assembled on AdML-Mut-PP7IVS is advantageous because it 
should enable isolation of complexes that do not have contamination of mature transcripts in them. 
This is because the presence of the PP7 tag in the intron should enable affinity purification only of 
complexes assembled on intron containing transcripts. As can be seen in Figure 5A, despite the 
mutation at the 3' splice site, low levels of mature RNA, one with skipping of exon 2 and another one 
with use of a cryptic 3' splice site were observed in the nuclear supernatants prepared from this cell 
line. However, the eluted material is devoid of mature RNA and only pre-mRNA is observed.  
The specificity of the affinity purification is demonstrated by the RT-PCR analysis (Figure 5A),  
by silver staining of SDS-PAGE (Figure 5B), and by the WB with anti-Sm antibodies (Figure 5C).  
EM visualization revealed supraspliceosomes similar to those observed for the WT transcripts  
(Figure 5D, upper panel), and similar in shape and dimensions to the 50 nm tetrameric quadrangular 
general population of supraspliceosomes [22,24]. Additionally, the dimensions of the native 
spliceosomes within the supraspliceosomes are similar to those found for the WT native spliceosomes. 
Also, the dimensions of the native spliceosomes within the supraspliceosomes are similar to those 
found previously for the general population of native spliceosomes [24,25], while no distinct 
complexes were observed in the control (Figure 5D, lower panel). 
We can conclude that affinity purified splicing complexes assembled on either AdML-WT or 
AdML-Mut transcripts are assembled in supraspliceosomes. AdML-WT supraspliceosomes are 
assembled on mature RNA, and ADML-Mut supraspliceosomes are assembled on pre-mRNA. 
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Figure 4. Analysis of affinity purified suprasliceosomes assembled on AdML-Mut-PP73'UTR. 
Nuclear supernatants prepared from cell lines stably expressing the AdML-Mut-PP73'UTR 
transcript, harboring the PP7 tag at the 3'UTR (left) or AdML-Mut transcript without the 
tag (right) were affinity purified. Aliquots from the different steps of the affinity 
purification procedure were analyzed by RT-PCR (A); silver staining of SDS-PAGE (B) 
and WB (C). Lanes 1 and 8, Nuclear Supernatant (Nuc. Sup., 10%); Lanes 2 and 9, material 
not bound to the beads (Unbound); Lanes 3–6 and 10–13, washes; Lanes 7 and 14, elution.  
(A) RT-PCR products were electrophoresed on 1% agarose gel. Their identity is given on 
the left, open boxes represent exons, line intron, arrowheads represent PCR primers.  
The expected size of each PCR product (nt) is given adjacent to its location on the left;  
(B) Proteins from the different steps of the affinity purification procedure were 
electrophoresed on 10% polyacrylamide gel and the gel was silver stained. Protein size 
marker is given on the left. *, heavy and light chains of the IgG antibody used for the 
affinity purification procedure. **, PP7CP protein; (C) Proteins from the different steps of 
the affinity purification procedure were electrophoresed on 12% polyacrylamide gel, 
transferred to a Nitrocellulose membrane and analyzed by WB using an anti-Sm antibody; 
(D) EM visualization. Upper panel, Gallery of electron micrographs of affinity purified 
supraspliceosomes assembled on AdML-Mut-PP73'UTR transcript, visualized by EM, after 
negative staining with 1% uranyl acetate; Lower panel, Control, electron micrograph of 
eluted material from the control sample (AdML-Mut transcript without the PP7 tag).  
The bar represents 50 nm. 
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Figure 5. Analysis of affinity purified suprasliceosomes assembled on AdML-Mut-PP7IVS. 
Nuclear supernatants prepared from cell lines stably expressing the AdML-Mut-PP7IVS 
transcript, harboring the PP7 tag at the intron (left) or AdML-Mut transcript without the tag 
(right) were affinity purified. Aliquots from the different steps of the affinity purification 
procedure were analyzed by RT-PCR (A); silver staining of SDS-PAGE (B) and WB (C). 
Lanes 1 and 8, Nuclear Supernatant (Nuc. Sup., 10%); Lanes 2 and 9, material not bound to 
the beads (Unbound); Lanes 3–6 and 10–13, washes; Lanes 7 and 14, elution. (A) RT-PCR 
products were electrophoresed on 1% agarose gel. Their identity is given on the left, open 
boxes represent exons, line intron, arrowheads represent PCR primers. The expected size 
of each PCR product (nt) is given adjacent to its location on the left; (B) Proteins from  
the different steps of the affinity purification procedure were electrophoresed on 10% 
polyacrylamide gel and the gel was silver stained. Protein size marker is given on the left. 
*, heavy and light chains of the IgG antibody used for the affinity purification procedure. 
**, PP7CP protein; (C) Proteins from the different steps of the affinity purification procedure 
were electrophoresed on 12% polyacrylamide gel, transferred to a Nitrocellulose membrane 
and analyzed by WB using an anti-Sm antibody; (D) EM visualization. Upper panel,  
Gallery of electron micrographs of affinity purified supraspliceosomes assembled on  
AdML-Mut-PP7IVS transcript, visualized by EM, after negative staining with 1% uranyl 
acetate. Lower panel, Control, electron micrograph of eluted material from the control 
sample (AdML-Mut transcript without the PP7 tag). The bar represents 50 nm. 
 
Each supraspliceosome is assembled on one pre-mRNA, as revealed by EM visualization of 
supraspliceosomes reconstituted from native spliceosomes and pre-mRNA tagged at its 3' end with one 
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Nanogold particle (1.4 nm) [32]. The four native spliceosomes of the supraspliceosome are connected 
by the pre-mRNA. In this configuration, the supraspliceosome acts as a multiprocessor that can 
simultaneously splice four introns, not necessarily in a consecutive manner [13]. As all RNA Pol II 
transcripts are assembled in supraspliceosomes, we proposed that splicing of multi-intronic transcripts 
is facilitated by translocation of the pre-mRNA through the complex [15,22]. In this “rolling model” 
after processing of four introns, the pre-mRNA rolls in to place a new subset of introns in the right 
position that allows their processing. The present study demonstrates that in the cell nucleus, 
transcripts having one intron are also assembled and processed in supraspliceosomes. This is in 
accordance with previous experiments with reconstituted supraspliceosomes, which showed that  
pre-mRNAs with less than four introns are also assembled in supraspliceosomes. Likely,  
the interactions of such RNA with the native spliceosomes are sufficient to hold the supraspliceosome 
structure together [15]. 
2.5. Supraspliceosomes Isolated from Cell Nuclei Are Assembled with All Five Spliceosomal  
U snRNPs during the Steps of the Splicing Reaction 
We have previously shown that supraspliceosomes isolated from mammalian cell nuclei have all 
five spliceosomal U snRNAs associated with them [14–16]. Furthermore, native spliceosomes,  
the subunits from which the supraspliceosome is composed, also harbor all five spliceosomal  
U snRNAs [15]. Our previous studies dealt with the steady state population of Pol II transcripts that 
differ in the number of their introns and exons and were at different stages of the splicing reaction. 
However, since in this study we affinity purified specific supraspliceosomes at defined functional 
states, we can analyze now the U snRNA composition of these specific supraspliceosomes.  
To this end, nuclear supernatants were prepared from each of the stable cell lines expressing:  
AdML-WT-PP73'UTR, AdML-Mut-PP73'UTR, AdML-Mut-PP7IVS, and from the control cell lines 
expressing AdML-WT, and AdML-Mut. Next, each of the nuclear supernatants was incubated with 
PP7CP and underwent through the affinity purification steps described above. After the affinity 
purification step, RNA was extracted from each of the nuclear supernatants and from each of the affinity 
purified samples prepared from it, and the RNA was electrophoresed on denaturing polyacrylamide gels. 
The gels were transferred to charged nylon membrane and hybridized simultaneously with [32P]RNA 
probes complementary to each of the five-spliceosomal U snRNAs. As can be seen in Figure 6A, all five 
spliceosomal U snRNAs were found associated with AdML-WT-PP73'UTR supraspliceosomes that  
are assembled on mature RNA (Lane 2), and on AdML-Mut-PP73'UTR and AdML-Mut-PP7IVS 
supraspliceosomes that are assembled on AdML pre-mRNA (Lanes 6 and 10, respectively). In the 
respective control samples that lack the PP7 tag (Lanes 4, 8, and 12), very low levels of U snRNAs are 
observed with some non specific binding of U1 snRNA, which is known to be in access in the cell 
nucleus [33]. Figure 6B presents averaging of the results of two experiments, where the y-axis depicts 
the ratio of the eluted material to the relevant nuclear supernatant. We can, therefore, conclude that 
supraspliceosomes isolated from mammalian cell nuclei have all five spliceosomal U snRNAs 
associated with them at all splicing stages. 
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Figure 6. The five spliceosomal U snRNPs are associated with supraspliceosomes 
assembled in vivo at all splicing stages. (A) Northern blot analysis with probes directed 
against the five spliceosomal U snRNAs was performed on RNA extracted from nuclear 
supernatants and from affinity purified splicing complexes prepared from HeLa cell-lines 
expressing the AdML constructs either with the PP7 tag or without it (−), as indicated. 
Left, the AdML-WT-PP73'UTR transcript; middle, the AdML-Mut-PP73'UTR transcript; 
Right, the AdML-Mut-PP7IVS transcript. RNA was extracted either from the nuclear 
supernatant (Nuc. Sup.), or from the affinity purified samples (Elution). Aliquots were 
electrophoresed on 7 M urea/10% polyacrylamide gel, transferred to a nylon membrane, and 
hybridized with [α-32P] UTP-labeled RNA probes against the U1, U2, U4, U5, and U6 
snRNAs, as described [15,16]. The identity of the U snRNA probes is given on the left;  
(B) Quantification of the Northern analyses. For each U snRNA molecule, the ratio between 
the signal of the eluted material and the relevant nuclear supernatant is shown. Each bar 
represents an average of two experiments; standard deviation is shown on the graph. 
 
Studies of spliceosome assembly in vitro revealed a stepwise assembly of spliceosomal U snRNPs 
during the splicing reaction [3,5], whereas the assembly of newly transcribed pre-mRNAs into 
supraspliceosomes in vivo appeared to involve pre-formed complexes [15,34,35]. Furthermore,  
the assembly pathway in vitro is characterized by major changes in composition (e.g., only three of the 
five spliceosomal snRNPs are part of the active C complex [36]). On the other hand, we have 
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previously shown that both the general population of supraspliceosomes and native spliceosomes 
contained all five spliceosomal snRNPs [15]. These findings were strengthened by the isolation of  
a functional “penta-snRNP” complex from yeast [34], and highlight the important role of large,  
pre-formed, complexes in pre-mRNA splicing in vivo. The present study that analyses the U snRNP 
composition of specific supraspliceosomes, of defined sequence and of defined functional state, 
revealed that the supraspliceosome is assembled with all five spliceosomal U snRNPs (Figure 6).  
The apparent discrepancy between the notion of a stepwise assembly pathway of the spliceosome  
in vitro and the occurrence of a pre-formed splicing complex in vivo, has been explained by a 
“holospliceosome” model, in which the sequential complexes represent ordered modulations within the 
in vivo assembled spliceosome without the loss of components [3]. It has also been pointed out that 
such distinct complexes, which represent intermediate states in spliceosome assembly in vitro, may not 
occur in vivo [34,37]. 
The assembly pathways of supraspliceosomes in vivo and that of spliceosomes assembled in vitro 
differ in the sense that the former occurs co-transcriptionally in the nucleus, whereas the assembly 
process in vitro occurs when a full-length pre-mRNA is interacting with the spliceosomal components 
present in a nuclear extract. We suggest that these two likely distinct pathways may lead to different 
local minima in the respective free energy profiles, which may result in the assembly of  
slightly different complexes. Alternatively, the observed changes in composition between intermediate 
complexes assembled in vitro, which are not found in supraspliceosomes assembled in vivo, may be 
due to the lack of specific components in the in vitro assembled complexes. Such missing components 
might help keep the in vivo assembled complexes intact. (e.g., in vitro assembled splicing complexes 
were usually isolated in the presence of heparin, which could have caused partial dissociation of 
components [38,39]). The assembly pathway of spliceosomes in vivo and in vitro is an important issue 
in understanding splicing and its regulation [40]. Our results contribute to a better understanding of the 
spliceosome assembly pathway in vivo. 
2.6. Protein Analysis of Affinity Purified Supraspliceosomes 
Analyses of the protein composition of spliceosomes were conducted thus far mainly of different 
spliceosome complexes assembled in vitro during the assembly pathway of the spliceosome and  
the splicing reaction [1,10,36,38,41,42], and of the general population of supraspliceosomes  
co-immunoprecipitated using anti-Sm MAbs [12]. Here, we were interested in analyzing the protein 
composition of specific supraspliceosomes at defined splicing stages. We, therefore, analyzed the 
affinity purified supraspliceosomes assembled on AdML-WT-PP73'UTR, AdML-Mut-PP73'UTR and 
AdML-Mut-PP7IVS transcripts by liquid chromatography-coupled mass spectrometry (Tables 1, 2  
and S1). Three analyses of the affinity purified supraspliceosomes assembled on mature mRNA 
(AdML-WT-PP73'UTR), and two analyses of the supraspliceosomes assembled on pre-mRNA (on the 
AdML-Mut transcripts) were performed. The analyses revealed an average of 275 protein groups, 
higher amount than the 177 protein groups detected previously for the analysis of a general population 
of supraspliceosomes purified from HeLa cells [12]. The difference in number of proteins is likely  
a result of the different purification methods and instrumentation used for analysis. We found that the 
location of the PP7 tag within the transcript, either in the 3'UTR or the intron, had no effect, since no 
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apparent differences were observed between the two AdML-Mut supraspliceosome populations. 
Similarly, the three AdML-WT assembled supraspliceosome populations gave a similar protein 
inventory; therefore, the results of the AdML-Mut supraspliceosomes analyses were combined for 
presentation, and so were the results for the AdML-WT supraspliceosomes. The main protein groups 
are shown in Table 1. 
Table 1. Mass Spectrometry (MS) analyses. 
Symbol Protein kDa AdML-WT AdML-Mut 
U1 snRNP 
SNRNP70 U1-70 k 51.5 +  
U2 snRNP 
SNRP A1 U2A' 28.4 +  
SNRP B2 U2B'' 25.5 +  
SF3A1 SF3a120 88.9 +  
SF3A2 SF3a66 49.3 +  
SF3A3 SF3a60 58.8 + + 
SF3B1 SF3b155 145.8 + + 
SF3B2 SF3b145 100.2 + + 
SF3B3 SF3b130 135.6 + + 
DDX46 PRP5 117.4 + + 
PHF5A SF3b14b 12.4 + + 
U2 snRNP related 
U2AF2 U2AF65 53.5 + + 
U4/U6.U5 snRNP 
PRPF8 U5-220k 273.6 + + 
SNRNP200 U5-200k 244.5 + + 
EFTUD2 U5-116k 109.5 + + 
PRPF6 U5-102k 106.9  + 
DDX23 U5-100k 93.2 + + 
PRPF3 U4/U6-90k 77.5 +  
PRPF4 U4/U6-60k 58.4 + + 
PRPF31 U4/U6.U5-61k 55.5 +  
Sm proteins 
SNRP B Sm B/B' 24.6 + + 
SNRP D1 Sm D1 13.3 + + 
SNRP D2 Sm D2 13.5 +  
SNRP D3 Sm D3 13.9 + + 
SNRP E Sm E 10.8 + + 
CK005235 Sm G Like 85.4 + + 
hPRP19/CDC5L complex 
PRPF19 PRPF19 55.2 + + 
CDC5L CDC5 92.3 +  
HSPA8 HSP71 70.9 + + 
PLRG1 PRP45 57.2 +  
XAB2 SYF1 99.7 +  
AQR Aquarius 156.8 +  
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Table 1. Cont. 
Symbol Protein kDa AdML-WT AdML-Mut 
Splicing factors 
DHX15 DHX15 89.5 + + 
DDX39 DDX39 49.1 + + 
DDX5 DDX5 p68 69.1 + + 
FUS FUS TLS 53.4 + + 
SFPQ hPOMp100 68.7 + + 
TIA1 p40-TIA-1 31.6 +  
Splicing factors 
NONO p54(nrb) 54.3 + + 
KHSRP p75 73.1 +  
PABPC1 PABP1 70.7 + + 
PUF60 PUF60 59.9 +  
RBM4 RBM4 40.2 +  
TARDBP TDP43 31.8 +  
DDX39B UAP56 50.7 + + 
YBX1 YBX1 35.9 + + 
hnRNP proteins 
HNRNPA0 hnRNP A0 30.8 + + 
HNRNPA1 hnRNP A1 38.8 + + 
HNRNPA3 hnRNP A3 39.6 + + 
HNRNPA2B1 hnRNP A2/B1 37.4 + + 
HNRNPC hnRNP C1/C2 33.7 + + 
RALY hnRNP CL2 24.7 + + 
HNRNPD hnRNP D 38.4 +  
HNRNPDL hnRNP DL 46.4 + + 
PCBP1 hnRNP E1 37.5 + + 
PCBP2 hnRNP E2 33.9 + + 
HNRNPF hnRNP F 45.7 + + 
RBMX hnRNP G 42.3 + + 
HNRNPH1 hnRNP H1 49.2 + + 
HNRNPH2 hnRNP H2 49.3 + + 
HNRNPH3 hnRNP H3 36.9 + + 
PTBP1 hnRNP I 57.2 + + 
HNRNPK hnRNP K 51 + + 
HNRNPL hnRNP L 64.1 + + 
HNRNPM hnRNP M 77.5 + + 
SYNCRIP hnRNP Q 69.6 + + 
HNRNPR hnRNP R 70.9 + + 
HNRNPU hnRNP U 90.6 + + 
HNRNPUL1 hnRNP UL1 95.7 + + 
HNRNPUL2 hnRNP UL2 85.1 + + 
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Table 1. Cont. 
Symbol Protein kDa AdML-WT AdML-Mut 
SR proteins 
SRSF1 SF2/ASF 28.3 + + 
SFR3 SRp20 19.3 + + 
SFR10 SFRS10 33.7 + + 
SRRM2 SRm300 299.6  + 
SFRS11 SRp54 24.8  + 
SRSF2 SRSF2 21.4  + 
SRSF6 SRp55 39.4 + + 
SRSF7 SRSF7 18.8 + + 
3' polyA/processing factors 
NUD21 CPSF 25 26.2 + + 
3' polyA/processing factors 
CPSF7 CPSF 59 51.1 + + 
CPSF6 CPSF 68 52.3 + + 
CPSF3 CPSF 73 73.5 +  
CPSF2 CPSF 100 88.5 +  
CPSF1 CPSF 160 152 +  
CSTF2 CSTF64 46.7 +  
PABPN1 PABII 11 + + 
SYMPK Symplekin 141.1 +  
Cap binding 
NCBP1 CBP80 91.8 +  
mRNA export and surveillance 
UPF1 UPF1 124.3 + + 
ALYREF ALYREF 27.6 +  
MAGOHB MAGOHB 17.3 +  
EIF4A3 eIF-4A-III 46.9 + + 
IGF2BP1 IMP-1 63.5 +  
RAN RAN 24.4 + + 
XPO1 Exportin 123.4 +  
RANBP2 RANBP2 358.2 + + 
RANGAP1 RANGAP1 63.5 +  
DDX3X DDX3X 73.2 + + 
RNA metabolism 
CSL4 CSL4 18.8 +  
DDX1 DBP-RB 82.4 + + 
DDX21 DDX21 87.3 + + 
DIS3 DIS3 109.1 +  
ELAVL1 HuR 39 + + 
LRPPRC LRP 130 157.9 +  
ILF2 NF45 43.1 + + 
NF90 NF90 76 + + 
ILF3 NF110 95.3 +  
NCL Nucleolin 76.6 + + 
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Table 1. Cont. 
Symbol Protein kDa AdML-WT AdML-Mut 
RNA metabolism 
NPM1 Nucleophosmin 32.6 + + 
PABPC4 PABP-4 70.8 + + 
EXOSC2 RRP4 32.8 +  
SKIV2L2 SKIV2L2 117.8 +  
SRRT SRRT 100.7 + + 
TIAL1 TIAL1 41.6 +  
Table 2. MS results for hnRNP isoforms. 
Accession Name kDa 
AdML-WT-
PP73'UTR 
AdML-WT- 
PP73'UTR 
AdML-WT-
PP73'UTR 
AdML-Mut-
PP73'UTR 
AdML-
Mut-PP7int 
P38152 hnRNP G 42.3 8 11  4 9 
Q00839 hnRNP U 90.6 50 57 11   
B4DLR3 hnRNP U 86.9    18 31 
PO9651 hnRNP A1 38.8   7   
Q61PF2 hnRNP A1 34.2  20  10 12 
Core components of the supraspliceosome were detected both in the AdML-WT and AdML-Mut 
assembled supraspliceosomes: The Sm proteins that are essential components of the spliceosome  
in vitro [1] and the supraspliceosome in vivo [12,20] were found at both supraspliceosome populations. 
Specific U snRNP proteins were also identified. Surprisingly, the U1 snRNP protein U1-70K, and the 
U2 snRNP proteins U2A' and U2B'' were not detected at the AdML-Mut assembled supraspliceosomes. 
The lack of detection of these proteins probably reflects lower levels of proteins in the mutant 
fractionation. This might be due to lower expression of AdML-Mut in the HeLa cell-lines in 
comparison to the AdML-WT expressing cell lines, or to lower amounts of material analyzed for the 
AdML-Mut assembled supraspliceosomes, or due to technical difficulties. However, the presence of 
these U snRNPs, as well as the tri-snRNPs were detected in both populations, as shown by the 
presence of other related snRNP proteins, and also by the definite Northern blot results (Figure 6) 
revealing the presence of the five U snRNAs, including U1 snRNA and U2 snRNA in both populations. 
Additional core components of the supraspliceosome found both at AdML-WT and AdML-Mut 
assembled supraspliceosomes is the hPRP19/CDC5L complex. The hPRP19/CDC5L complex that was 
previously shown to be necessary for both splicing stages [43–46] was also identified at the proteomic 
analysis of the general supraspliceosome population [12]. Studies in vitro showed that this complex 
joins the spliceosome together with the U4/U6.U5 tri-snRNP and remains associated with the 
spliceosome during both steps of splicing [38,47]. Our results for the hPRP19/CDC5L complex are 
consistent with the latter in vitro findings showing its association with the splicing complex during the 
splicing steps. Another group of proteins detected in both supraspliceosome populations (assembled  
on AdML-WT or AdML-Mut transcripts) were proteins responsible for pre-mRNA processing.  
These included: components of the cleavage and polyadenylation specificity factor (CPSF) that is 
responsible for 3' end processing [48–50]; editing proteins [21,51]; and the ALY/REF proteins which 
play a role in RNA export from the nucleus [52]. It should be pointed out that the presence of 3' end 
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processing components [20] and the presence of ADAR (adenosine deaminases acting on RNA) 
enzymes [21] in supraspliceosomes was previously shown. The finding of these factors here, stresses 
the fact that the supraspliceosome is a machine responsible for the general RNA processing events in 
the cell. 
The MS analyses further showed that several splicing factors and other proteins involved in RNA 
metabolism were associated with supraspliceosomes assembled on AdML-WT and AdML-Mut 
transcripts. The analyses revealed the presence of the RNA binding proteins SR and hnRNP families at 
both AdML-WT and AdML-Mut assembled supraspliceosomes. These proteins, which play a role in 
alternative and constitutive RNA splicing [52], were previously shown to be a part of the 
supraspliceosome [14,16,17,32]. It should be pointed out that shotgun proteomics, as was used here, is 
a technology that maps the composition of protein samples with an element of stochastic coverage. 
This is especially true for label-free quantitation, employed here. The biological replica had a wide 
spread, indicating additional challenges resulting from the biochemical isolation procedure. This was 
addressed to a level that allows discussing trends of protein composition of the WT and Mut 
supraspliceosomes. Regarding lack of expected factors as well as interesting hypothesis derived from 
candidates for specific factors one will have to wait for more in depth proteomic analyses, possibly 
using stable isotope labelling by amino acids in cell culture (SILAC) for better quantitation as samples 
are mixed early on and the biochemical isolation procedure then has no impact on the relative  
protein composition. 
Deeper analysis of the hnRNP proteins revealed different alternatively spliced isoforms of a number 
of hnRNP proteins at different stages of splicing (Table 2). While for hnRNP G, a single isoform was 
detected, present in both AdML-WT and AdML-Mut assembled supraspliceosomes, in the cases of 
hnRNP U and of hnRNP A1 proteins, two isoforms were detected. The full-length isoform of hnRNP 
U and of hnRNP A1 was detected only within the AdML-WT assembled supraspliceosomes,  
whereas the shorter isoform of hnRNP U was detected only within the AdML-Mut assembled 
supraspliceosomes, and the shorter isoform of hnRNP A1 was detected in both populations. Western Blot 
analysis of proteins associated with AdML-WT and AdML-Mut assembled supraspliceosomes (Figure 7), 
showed that hnRNP G is present in both complexes, similar to the Sm proteins, thus validating the MS 
results (Table 1). In the case of ILF3, which is involved in transcription, this 110 kDa isoform is found 
associated with supraspliceosomes assembled on AdML-WT transcripts and not on supraspliceosomes 
assembled on AdML-Mut transcripts, also in agreement with the MS results (Table 1). We also 
validated the MS results showing different alternatively spliced isoforms for hnRNP U and of hnRNP 
A1 proteins at different stages of splicing (Table 2). Thus, the full-length isoform of hnRNP U and of 
hnRNP A1 was detected only within the AdML-WT assembled supraspliceosomes, when analyzed by 
WB, using antibodies that recognize only the full-length respective protein (Figure 7). 
The proteomic analyses of supraspliceosomes assembled on AdML-WT and AdML-Mut transcripts 
strengthen the above conclusion that the supraspliceosome is the pre-mRNA processing machine that 
is pre-assembled throughout all splicing stages, as the core components of the spliceosome can be seen 
in all these stages. The analyses also show the dynamic nature of the supraspliceosome during the 
splicing stages, as different hnRNP isoforms were found in supraspliceosomes from the different steps 
of splicing. 
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Figure 7. WB analyses of proteins associated with supraspliceosomes assembled on  
AdML-WT and AdML-Mut transcripts confirm the MS results. Nuclear supernatants were 
prepared from each of the HeLa cell lines, stably expressing either the AdML-WT-PP73'UTR, 
the AdML-Mut-PP73'UTR, or the AdML-Mut-PP7IVS transcripts, and supraspliceosomes 
assembled on each of the respective PP7-tagged transcripts were affinity purified, as 
described above. Proteins from each of the nuclear supernatants (Nuc. Sup., left) and from 
each the affinity purified supraspliceosomes (Elution, right) were extracted, electrophoresed 
on 8% polyacrylamide gel and analyzed by WB. The different antibodies used for the WB 
analyses are given on left. 
 
3. Experimental Section 
Plasmid construction and cell culture. AdML-WT and AdML-Mut constructs in pSP72 were kindly 
provided by Prof. Reed R (Harvard Medical School, Boston, MA, USA). The AdML-WT and  
AdML-Mut fragments share identical exon 1 (70 nucleotides). While AdML-WT construct contains 
intron 1 (123 nucleotides) and exon 2 (51 nucleotides), the AdML-Mut construct harbors an elongated 
undisturbed pyrimidine tract, and a mutated 3' splice site from CAG to TGG. The second exon of 
AdML-Mut is essentially the same in length and sequence as in AdML-WT, except for the change in 
sequence of nucleotides 2–5 from TGCA to CATG. Both constructs were digested with VspI, filled in 
with Klenow fragment, and ligated to EcoRV digested pcDNA3 vector. The AdML-Mut construct was 
then further mutated (QuikChange™ site-directed mutagenesis kit; Agilent Technologies, Santa Clara, 
CA, USA) from CAG to CGG in order to prevent downstream exonic alternative 3' splice site using 
the primers 5'-TCGCGGTCTTTCCGGTACTCTTGGATCCG-3'; 5'-CGGATCCAAGAGTACCGG 
AAAGACCGCGA-3'. 
PP7 tag was inserted to the 3'UTR of AdML-WT construct by performing Klenow reaction on the 
partially complementary single-stranded oligos: 5'-TTGCTAGCGCGGCCGCTAAGGAGTTTA 
TATGGAAACCCTTAGACGTCGGCACGAGG-3'; and 5'-TTCTCGAGGGGCCCGGCACGA 
GTGTAGCTAAACCTCGTGCCGACGTCTAAGGG-3'. The double stranded product was then 
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digested with ApaI and NotI, and ligated to the pcDNA-AdML-WT plasmid, digested with the same 
restriction enzymes, generating the pcDNA-AdML-WT-PP73'UTR plasmid, that harbors the PP7 tag 
at the 3'UTR of AdML. 
For the insertion of the PP7 tag into the 3'UTR of AdML-Mut construct, first, annealing of the 
following single-stranded oligos: 5'-GGCCGCTAAGGAGTTTATATGGAAACCCTTAGGGCC-3'; 
and 5'-CTAAGGGTTTCCATATAAACTCCTTAGC-3' was preformed for 2 min at 98 °C, 2 additional 
minutes at 70 °C, and gradually cooling to 40 °C in the presence of 5 mM MgCl2. 
Next, ligation of the resulting double stranded oligo to ApaI digested pcDNA-AdML-Mut, 
generated the pcDNA-pcDNA-AdML-Mut-PP73'UTR plasmid that harbors the PP7 tag at the 3'UTR 
of AdML. For the generation of pcDNA-AdML-Mut-PP7IVS, the pcDNA-AdML-Mut-PP73'UTR 
plasmid was digested with NotI and ApaI and self-ligated in order to remove the PP7 tag, followed  
by insertion of the double stranded oligo to the XhoI site of the plasmid, generating the  
pcDNA-AdML-Mut-PP7IVS plasmid that harbors the PP7 tag at the AdML intron. All constructs were 
confirmed by sequencing. 
Next, five cell lines were generated, each stably expressing one of the above five constructs:  
(i) AdML-WT-PP73'UTR, that harbors the PP7 tag at the 3'UTR of AdML; (ii) AdML-WT, without 
the tag; (iii) AdML-Mut-PP73'UTR, that harbors the PP7 tag at the 3'UTR; (iv) AdML-WT-PP7IVS, 
that harbors the PP7 tag at the intron; and (v) AdML-Mut, without the tag. For this aim each of the 
above five plasmids was transfected to a HeLa cell-line using jetPEI™ transfection reagent. The cells 
were maintained in DMEM supplemented with 10% fetal calf serum and antibiotics for 24 h, then the 
DMEM was replaced to one which also contains 500 μg/mL G-418 antibiotics, allowing resistant cell 
colonies to appear several days afterwards. The resulting cell-lines were analyzed for the presence of 
the constructs by RNA extraction followed by RT-PCR and sequencing. 
Protein purification. The plasmid pET28-ZZTEVPP7CP, for expressing the ZZTEVPP7CP protein 
was kindly provided by Prof. Collins K (University of California at Berkeley, Berkeley, CA, USA).  
The expression and purification of the protein was preformed as described [29]. 
The vector for TEV protease expression was kindly provided by Prof. David S. Waugh  
(National Cancer Institute at Frederick, Frederick, MD, USA) and expressed and purified at the 
Wolfson Centre for Applied Structural Biology, the Hebrew University of Jerusalem, Jerusalem, Israel. 
Affinity purification of PP7 tagged splicing complexes. The affinity purification was performed as 
described [29] with some changes and without using the tobramycin step. All steps were conducted at 
4 °C, with mild agitation. To 500 μL of the nuclear supernatants, originated from ~0.5–1 × 108 cells,  
1 μg of ZZTEVPP7CP protein was added in a solution of: 10% (v/v) glycerol, 0.1% (v/v) NP-40,  
0.5 mM phenylmethylsulfonyl fluoride (PMSF), final concentration; and incubated for 90 min with 
rotation. Next, 250 μg of IgG agarose beads (Sigma Aldrich, Rehovot, Israel) pre-washed with binding 
buffer (10% (v/v) glycerol, 10 mM Tris pH 8, 2 mM MgCl2, 100 mM NaCl, 1 mM  
DL-dithiothreitol (DTT), 0.1% (v/v) NP-40, 0.5 mM PMSF and 2 mM vanadyl ribonucleoside (VR)) 
were added, followed by additional rotation for 90 min. Three washing steps with binding buffer and 
another one with TEV buffer (10% (v/v) glycerol, 10 mM Tris pH 8, 2 mM MgCl2, 100 mM NaCl and 
1 mM DTT) were preformed for 10 min each. Elution of the bound material from the beads was 
performed by incubating the beads overnight with 1 μg of TEV protease in 50 μL TEV buffer.  
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The supernatant was then transferred to a new tube. Samples were taken either for analyses or for 
further isolation by glycerol gradients. 
Isolation of supraspliceosomes. All isolation steps were conducted at 4 °C. Nuclear supernatants 
enriched in supraspliceosomes were prepared as described [14,53]. Briefly, nuclear supernatants were 
prepared from purified cell nuclei by microsonication of the nuclei and precipitation of the chromatin 
in the presence of transfer RNA. The nuclear supernatant was fractionated on 10%–45% (v/v) glycerol 
gradients. Centrifugations were carried out at 4 °C in an SW41 rotor run at 41 krpm for 90 min (or an 
equivalent w2t). The gradients were calibrated with tobacco mosaic virus as a 200S sedimentation marker. 
Protein analyses. For protein analyses, samples were acetone-precipitated, electrophoresed on  
SDS-polyacrylamide gels, and were either stained or blotted. 
For total protein visualization by silver staining, the proteins were fixed in 40% ethanol, 10% acetic 
acid for 60 min, washed in double distilled water (DDW) for at least 30 min, sensitized in 0.02% 
Na2S2O3 for 1 min, and washed 3 times in DDW, 20 s each. The gel was then incubated in a solution 
of 0.1% AgNO3 and 0.074% formaldehyde for 20 min, and washed afterwards 3 times in DDW,  
20 s each, and for additional 1 min. Development was performed in 3% Na2CO3, 0.02% formaldehyde, 
and the reaction was stopped in 5% acetic acid for 5 min. 
WB analyses were performed using anti-Sm MAb Y12 [54]; anti-hnRNP U (Santa Cruz 
Biotechnology, Dallas, TX, USA); anti hnRNP A1 (Abcam, Tel Aviv, Israel); anti ILF3  
(BD Biosciences, Franklin Lakes, NJ, USA), and visualized with horseradish peroxidase conjugated to 
affinity-pure Goat anti-Mouse IgG (H + L; Jackson Immunoreaserch, West Grove, PA, USA) diluted 
1:3000; anti-hnRNP G kindly provided by Stefan Stamm (University of Kentucky, Lexington, KY, 
USA), visualized with horseradish peroxidase conjugated to affinity-pure Goat anti-Rabbit IgG (H + L; 
Jackson Immunoreaserch) diluted 1:10,000. 
For mass spectrometry analyses, the proteins were acetone-precipitated, electrophoresed 1 mm into 
NuPAGE 4%–12% Bis-Tris gel (Life Technologies, Modiin, Israel), and stained using the colloidal 
blue staining kit (Life Technologies), according to the manufacturer’s instructions. Each sample 
corresponded to a single band of coomassie-stained gel and was excised. The proteins where digested 
using Trypsin as described elsewhere [55]. In brief, proteins were reduced in 10 mM DTT for 30 min at 
37 °C, alkylated in 55 mM iodoacetamide for 20 min at room temperature in the dark, and digested 
overnight at 37 °C with 12.5 ng/μL Trypsin (Proteomics Grade, Sigma, St. Louis, MO, USA).  
The digestion solution was then acidified to 0.1% of TFA and spun onto StageTips as described in the 
literature [56]. Peptides were eluted in 20 μL of 80% acetonitrile in 0.1% TFA and were concentrated 
to 4 μL (Concentrator 5301, Eppendorf AG, Hamburg, Germany). The peptides sample was then 
diluted to 5 μL by 0.1% TFA for LC-MS/MS analysis. 
Analyses were performed using a LTQ-Orbitrap mass spectrometer (Thermofisher Scientific, 
Waltham, MA, USA) coupled on-line to an Agilent 1200 binary nano pump (Palo Alto, CA, USA) and 
an HTC PAL autosampler (CTC, Zwingen, Switzerland). The analytical column with a self-assembled 
particle frit [57] and C18 material (ReproSil-Pur C18-AQ 3 μm; Dr. Maisch, GmbH, Ammerbuch, 
Germany) was packed into a spray emitter (75-μm ID, 8-μm opening, 300-mm length; New Objective, 
Woburn, MA, USA) using an air-pressure pump (Proxeon Biosystems, Vienna, Austria). Mobile phase 
A consisted of 5% acetonitrile and 0.5% acetic acid in water; mobile phase B, consisted of 0.5% acetic 
acid in acetonitrile. The peptides were loaded onto the column at a flow rate of 0.7 μL/min and eluted 
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at a flow rate of 0.3 μL/min using a three-step linear gradient raising to 5% buffer B in 1 min, followed 
by increase to 23% buffer B in 135 min and then to 80% buffer B in 10 min. 
FTMS spectra were recorded at 60,000 resolution and the six most intense peaks of the MS scan 
were selected in the ion trap for MS2, (normal scan, wideband activation, filling 5.0 × 105 ions for MS 
scan, 1.0 × 104 ions for MS2, maximum fill time 100 ms, dynamic exclusion for 180 s). Searches were 
conducted using Mascot against a database containing human sequences [58]. The search parameters 
were: MS accuracy, 6 ppm; MS/MS accuracy, 0.6 Da; enzyme, trypsin; allowed number of missed 
cleavages, 2; fixed modification, carbamidometylation on Cysteine; variable modification, oxidation 
on Methionine. 
RNA isolation and RT-PCR analyses. For RNA extraction, samples (up to 250 μL) in 10% (v/v) 
glycerol, 10 mM Tris pH 8, 100 mM NaCl, 2 mM MgCl2 and 2 mM VR were mixed with 75 μL of 
extraction buffer (50 mM Tris pH 7.5, 150 mM NaCl) and 25 μL of 10% (w/v) SDS. The RNA was 
recovered by extraction with phenol and precipitation in ethanol. The RNA was treated with DNase I 
(50 U/mL; Promega, Madison, WI, USA). cDNA was synthesized from up to 3 µg of RNA, using 
dT15 primer and MMLV reverse transcriptase (Promega). PCRs (20 µL) containing 2.5 µL of the 
cDNA products, 10 pmol of the relevant primers and 1 U of Taq DNA polymerase (Promega) were 
preformed. The following primer pairs were used: Actin: 5'-CAAGGCCAACCGCGAGAAGATGAC-3' 
and 5'-AGGAAGGAAGGCTGGAAGAGTGC-3'; AdML: 5'-AATTCGAGCTCGGTACCCC-3' or  
5'-GTTCGTCCTCACTCTCTT-3' and 5'-GAGGGGCAAACAACAGATGG-3'. 
Electron microscopy. 10 μL aliquots of the samples were absorbed on glow-discharged carbon-coated 
grids and negatively stained with 1% uranyl acetate. A Tecnai 12 TEM (FEI, Eindhoven, The 
Netherlands), operating at acceleration voltage of 100 kV, equipped with a 1 K × 1 K TEMcam CCD 
camera was used (TVIPS, Gauting, Germany). 
U snRNA analysis. For Northern blot analysis, RNA was extracted from the nuclear supernatants or 
from the affinity purified splicing complexes prepared from the stable cell lines described above, and 
electrophoresed on a 7 M urea/10% polyacrylamide gel. The RNA was then transferred to a Hybond-XL 
membrane (GE healthcare, Pittsburgh, PA, USA) and hybridized with [α-32P] UTP-labeled RNA 
transcripts, each complementary to either U1, U2, U4, U5, and U6 snRNAs as described [15,16], with 
minor changes. Briefly, the U snRNA plasmids were linearized, extracted with phenol and precipitated 
in ethanol. 1 μg from each plasmid was used as template for in vitro splicing reaction (20 μL), which 
also contained 0.5 mM ATP, 0.5 mM CTP, 5 mM GTP, 0.25 mM UTP, 40 mM Tris pH 7.5, 6 mM 
MgCl2, 10 mM DTT, 10 mM NaCl, 2 mM spermidine, 50 U RNasin (EURX, Gdansk, Poland), 20 μCi 
of [α-32P] UTP (PerkinElmer, 3000 Ci/nmol) and 20 U of RNA polymerase (Promega). The reaction 
was preformed for 90 min at 37 °C, and cleaned with Sephadex G-25 beads (Sigma Aldrich, St. Louis, 
MO, USA). Hybridization was performed by overnight incubation of the membrane, at 65 °C, with  
1.5 × 107 cpm mix of the five RNA probes in 10 mL hybridization buffer (340 mM Na2HPO4, 160 mM 
NaH2PO4, 1% BSA, 7% SDS, 1 mM EDTA). The membrane was then washed with 3 consecutive 
washing buffers [washing buffer #1 (2× SSC, 0.1% SDS); washing buffer #2 (1× SSC, 0.1% SDS); 
washing buffer #3 (0.1× SSC, 0.2% SDS)], for 15 min each. Washing with washing buffer 1 was 
performed at room temperature. Washing with buffers 2 and 3 were performed at 65 °C.  
The membrane was exposed to a phosphorimager. Bands were quantified with Image Gauge version 
3.46 software (FUJIFILM, Benei Brak, Israel). 
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4. Conclusions 
Isolation and characterization of splicing complexes assembled in vivo on specific transcripts, at 
defined functional states, revealed that they are assembled in supraspliceosomes at all splicing stages. 
This study also demonstrated that in cell nuclei, transcripts having one intron are also assembled and 
processed in supraspliceosomes. This is in accordance with previous experiments with reconstituted 
supraspliceosomes, which showed that pre-mRNAs with less than four introns are also assembled  
in supraspliceosomes [15]. Likely, the interactions of the RNA with the substructures of the 
supraspliceosome are sufficient to hold the structure together [15]. Analysis of the U snRNA 
composition of these supraspliceosomes revealed that they are assembled with all five U snRNAs  
at all splicing stages. We can, thus, conclude that dynamic changes in base-pairing interactions of  
U snRNA:U snRNA and U snRNA:pre-mRNA that occur in vivo during the splicing reaction do not 
require changes in U snRNP composition of the supraspliceosome. We can further conclude that 
supraspliceosomes isolated from mammalian cell nuclei are pre-assembled splicing complexes at all 
splicing stages. Furthermore, there is no need to reassemble a native spliceosome for the splicing of 
each intron, and rearrangements of the interactions will suffice. Protein composition analyses of 
specific supraspliceosomes assembled on mature and precursor molecules show that the core splicing 
components are present at all splicing stages, supporting the pre-assembled nature of the supraspliceosome. 
The dynamic nature of the splicing machine was also shown, as some differences in protein 
composition were observed in supraspliceosomes at the different splicing stages. The finding of RNA 
processing components, such as 3' end processing and RNA editing, as integral components of 
supraspliceosomes further support the notion that the supraspliceosome is the nuclear pre-mRNA 
processing machine. 
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